Newsfile Corp. is a press release service for companies of all sizes. With a distribution of over 6,000 media and financial databases, Newsfile delivers press releases to a global audience.
BUSINESS ACCOUNT
Sign up for a business account to:
-
Access reports individually or via Subscription
-
Receive monthly invoices with payment via CSA or hard dollars
Get access to other exclusive features
-
Analyst access
-
Free Trial Subscriptions
-
Team account with shared subscriptions
-
Advanced analytics to track research consumption and performance
Thiogenesis Therapeutics' MELAS Abstract Accepted for Late-Breaking Ne...
San Diego, California--(Newsfile Corp. - January 13, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondrial and metabolic diseases, today announced that an abstract outlining preliminary results from its Phase 2 clinical trial of TTI-0102 for Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) in the EU has been accepted as Late-Breaking News for presentation at the Mitocon Conference 2026, which will take place...
Gorilla Technology Announces Three New Project Wins in Taiwan Across P...
London, United Kingdom--(Newsfile Corp. - January 13, 2026) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology today announced it has secured three new project wins in Taiwan secured between 30th December 2025 and 5th January 2026. The awards extend Gorilla's active deployments across public safety critical infrastructure and environmental protection. These agreements will provide a meaningful contribution to revenue, but contract values will n...
NANO Nuclear Energy Signs MOU with DS Dansuk to Advance Micro Modular ...
Collaboration will seek to access South Korea's industrial base, regulatory institutions, and regional networks, accelerating NANO Nuclear's expansion across AsiaNew York, New York--(Newsfile Corp. - January 13, 2026) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or the "Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced the signing of a Memorandum of Understanding (MOU) with DS Dansuk Co., Ltd., a publicly listed company on the Seoul Stock Exchange and a leading South Korean industri...
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in ...
Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients.Activation of additional top-tier clinical sites in Europe and Canada underway, further accelerating enrollment momentum.Full enrollment expected in Q2 2026.Toronto, Ontario--(Newsfile Corp. - January 13, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has...
F3 More Than Doubles Tetra Zone Length to 135m
Kelowna, British Columbia--(Newsfile Corp. - January 13, 2026) - F3 Uranium Corp (TSXV: FUU) (OTCQB: FUUFF) ("F3" or "the Company") is pleased to announce final scintillometer results from its 2025 fall drill program on the Tetra Zone on the Broach Property. The program consisted of five diamond drill holes totaling 2,628m and extended the interpreted mineralized plunge length from 60m to 135m, an increase of 125%. Sam Hartmann, Vice President Exploration, commented:"The fall 2025 program was designed to test the plunge continuity of uranium mineralization in the Tetra Zone shear. Drilling ext...
